SAN FRANCISCO, March 17 /PRNewswire/ -- The organizers of the Antibody World Summit series are pleased to announce that the revamped 2006 meeting will take place in San Francisco June 12-14. The 5th annual conference is heavily attended by both the industrial and academic antibody communities from around the world. Scientists and executives gather to present their latest work, posters, and network during the three-day extravaganza. Strategic Research Institute is pleased to unveil the keynotes for the 2006 meeting as follows:
Delivering on the Promise of Antibody Therapeutics: Addressing the Demands of a Challenging Future
Jim Thomas, Ph.D. Vice President, Process & Analytical Sciences AMGEN, INC. Synthetic Human Antibodies in Development Sachdev Sidhu, Ph.D. Department of Protein Engineering GENENTECH, INC.
Development of Mapatumumab (HGS-ETR1), a Fully Human mAb with Agonist Function to Tumor Necrosis Factor Apoptosis-Inducing Ligand (TRAIL) Receptor-1
Gilles Gallant, B.Pharm. Ph.D. Vice-President, Clinical Oncology HUMAN GENOME SCIENCES Moving Toward the Next Generation of Biopharmaceutical Manufacturing Paul Marshall Vice President of Corporate Manufacturing AMGEN, INC
The 2006 meeting has added a new track focusing exclusively on monoclonal antibodies in cancer in response to the overwhelming number of MAbs being developed to effectively treat its multiple forms. The multiple meeting tracks also cover antibody discovery and pre-clinical development, formulation, manufacturing, and business development topics.
The final meeting agenda will be unveiled in the next two weeks and in the meantime final speaker submissions are being accepted. Those who have not yet submitted abstracts may do so as follows by contacting the following organizers by Wednesday, March 22. Abstracts should be titled, 50-100 words in length, with full presenter information.
For manufacturing topics, contact Glenn Pascual at gpascual@srinstitute.com or 212.967.0095, extension 245; For MAbs in Cancer, contact Ed Drilon at edrilon@srinstitute.com or 212.967.0095, extension 233; and for Antibody Discovery & Pre-Clinical Development, contact Mark Alexay at malexay@srinstitute.com or 212.967.0095, extension 251.
The exhibit hall still has plenty of space, the best of which is awarded to early registrants who also receive a discount. Contact Mark Alexay at malexay@srinstitute.com or 212.967.0095, extension 251 to register early.
To inquire on how to become a media partner, please contact Cheryl Kahan- Radhuber at ckahan-radhuber@srinstitute.com.
Contact Mark Alexay at malexay@srinstitute.com or 212.967.0095, extension 251.
Strategic Research Institute
CONTACT: Mark Alexay, +1-212-967-0095, extension 251,malexay@srinstitute.com
Web site: http://www.srinstitute.com/
